P-SCN-Bn-DOTA( —— )

Catalog No. M35058 CAS No. 127985-74-4

p-SCN-Bn-DOTA is a chelator that simultaneously binds radionuclides and links monoclonal antibodies.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	151	In Stock
5MG	123	In Stock
10MG	188	In Stock
25MG	353	In Stock
50MG	533	In Stock
100MG	759	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

P-SCN-Bn-DOTA
Note

Research use only, not for human use.
Brief Description

p-SCN-Bn-DOTA is a chelator that simultaneously binds radionuclides and links monoclonal antibodies.
Description

p-SCN-Bn-DOTA is a bifunctional chelating agent. p-SCN-Bn-DOTA can simultaneously chelate radionuclides and link monoclonal antibody for radioimmunoresearch of tumor.
In Vitro

p-SCN-Bn-DOTA is complexed with 5 different metal ions: In(III), Y(III), Lu(III), Gd(III) and Cu(II).
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

127985-74-4
Formula Weight

551.61
Molecular Formula

C24H33N5O8S
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 20.83 mg/mL (37.76 mM; Ultrasonic (<60°C)
SMILES

OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)C(Cc2ccc(cc2)N=C=S)CN(CC(O)=O)CC1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Vera DRB, et, al. Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors. Cancer Biother Radiopharm. 2011 Jun;26(3):287-97.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks